Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial-Reference-Cited by-同舟云学术

Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial

Published:2024-02 Issue:2 Volume:6 Page:e81-e91
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Redl Anna,Doberer Konstantin,Unterluggauer Luisa,Kleissl Lisa,Krall Christoph,Mayerhofer Carolina,Reininger Bärbel,Stary Victoria,Zila Nina,Weninger Wolfgang,Weichhart Thomas,Bock Christoph,Krausgruber Thomas,Stary Georg

Funder

Vienna Science and Technology Fund

Austrian Science Fund

European Research Council

Publisher

Elsevier BV

Reference34 articles.

1. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders;Costabel;Eur Respir J,1999

2. Sarcoidosis;Valeyre;Lancet,2014

3. Cutaneous sarcoidosis;Caplan;Semin Respir Crit Care Med,2020

4. Challenges of sarcoidosis and its management;Drent;N Engl J Med,2021

5. Quality of life in sarcoidosis;Judson;Semin Respir Crit Care Med,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cytokine networks in neuroinflammatory diseases;Nature Reviews Drug Discovery;2024-09-11

2. Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative Review;Biomedicines;2024-07-06

3. Treatment of refractory cutaneous dermatomyositis with oral sirolimus;Clinical and Experimental Dermatology;2024-06-03

4. Humoral pathways of innate immune regulation in granuloma formation;Trends in Immunology;2024-06

5. Sarcoidosis immunopathogenesis – a new concept of maladaptive trained immunity;Trends in Immunology;2024-06